GlassScriptPhysician profile
David R Kritz
NPI 1346376142
$11,752.08
in general payments reported to CMS, 2019-2025
38 companies · $2,958 in 2025
The $2,958 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,832 · 2020: $486 · 2021: $1,195 · 2022: $1,497 · 2023: $1,544 · 2024: $2,240 · 2025: $2,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,742.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,444.58 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $968.64 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $936.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $766.04 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Amgen INC. | $740.23 | 2019-2025 | Repatha, Otezla, Otezla |
| Merck Sharp & Dohme LLC | $659.79 | 2019-2025 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Janssen Pharmaceuticals, INC | $644.98 | 2019-2025 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $564.52 | 2019-2025 | Jardiance, Tradjenta |
| Bayer Healthcare Pharmaceuticals INC. | $440.20 | 2021-2025 | |
| Abiomed | $439.18 | 2022-2024 | Impella |
| Phathom Pharmaceuticals, INC. | $402.78 | 2024-2025 | Voquezna |
| Pfizer INC. | $370.01 | 2019-2024 | |
| Boston Scientific Corporation | $320.32 | 2019-2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $248.89 | 2019-2023 | |
| Abbvie INC. | $244.37 | 2021-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $207.39 | 2019-2021 | |
| Abbott Laboratories | $149.78 | 2019-2025 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $147.80 | 2025 | Zoryve |
| Exact Sciences Corporation | $115.10 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $105.01 | 2019-2024 | |
| Teleflex LLC | $98.12 | 2023 | Urolift |
| Dexcom, INC. | $96.95 | 2021-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $85.11 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.25 | 2019 | |
| Sanofi Pasteur INC. | $70.27 | 2019-2025 | |
| Exeltis, USA INC. | $52.13 | 2023 | Slynd |
| Ucb, INC. | $48.02 | 2025 | Briviact |
| Teva Pharmaceuticals USA, INC. | $44.62 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $43.51 | 2019-2021 | |
| Grifols USA, LLC | $37.08 | 2019 | |
| Daiichi Sankyo INC. | $34.81 | 2019-2021 | |
| Hologic Sales and Service, LLC | $28.60 | 2025 | Aptima |
| Averitas Pharma INC. | $22.87 | 2023 | Qutenza |
| Sun Pharmaceutical Industries INC. | $22.23 | 2022 | |
| Mayne Pharma Commercial LLC | $21.95 | 2023 | |
| Edwards Lifesciences Corporation | $17.46 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Ultragenyx Pharmaceutical INC. | $15.63 | 2019 | |
| Eisai INC. | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kritz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.